Sandu Camelia, Bica Cristina, Salmen Teodor, Stoica Roxana, Bohiltea Roxana, Gherghiceanu Florentina, Pacu Irina, Stefan Simona, Serafinceanu Cristian, Stoian Anca Pantea
National Institute of Diabetes, Nutrition and Metabolic Diseases 'Prof. N.C. Paulescu', 020475 Bucharest, Romania.
Department of Diabetes, Nutrition and Metabolic Diseases, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Exp Ther Med. 2021 Jan;21(1):81. doi: 10.3892/etm.2020.9512. Epub 2020 Nov 26.
Gestational diabetes mellitus is an important healthcare problem with serious implications both to the mother and to the foetus. The necessity of clear screening criteria for the pregnant woman and also identifying from an early stage the risk groups can be beneficial instruments for better management of gestational diabetes. The present report identify the main screening criteria for patients at risk for gestational diabetes and the therapeutic-nutritional therapy for women that have gestational diabetes. The different diagnostic criteria, as well as the new instruments through which these criteria can be applied, are still heterogeneous, and it is necessary to unify and promote them. The prevalence of gestational diabetes has significantly increased in recent years, and this has led to an increase in the direct and indirect costs of healthcare. Establishing the optimal time and initiating the correct treatment is critical to achieving glycemic control and to minimize the impact on fetal development and perinatal complications.
妊娠糖尿病是一个重要的医疗保健问题，对母亲和胎儿都有严重影响。为孕妇制定明确的筛查标准以及从早期识别风险群体，可能是更好管理妊娠糖尿病的有益手段。本报告确定了妊娠糖尿病高危患者的主要筛查标准以及患有妊娠糖尿病女性的治疗性营养疗法。不同的诊断标准以及应用这些标准的新手段仍然参差不齐，有必要进行统一和推广。近年来，妊娠糖尿病的患病率显著上升，这导致了医疗保健直接和间接成本的增加。确定最佳时间并开始正确治疗对于实现血糖控制以及尽量减少对胎儿发育和围产期并发症的影响至关重要。
